Adherium Limited (ADR.AX)
AUD 0.01
(9.09%)
AUD 0.01
(9.09%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | -640.83 Thousand AUD | -137.87% |
| 2023 | 1.69 Million AUD | 345.22% |
| 2022 | -690 Thousand AUD | 12.55% |
| 2021 | -789 Thousand AUD | -216.54% |
| 2020 | 677 Thousand AUD | -58.87% |
| 2019 | 1.64 Million AUD | -65.48% |
| 2018 | 4.76 Million AUD | 310.68% |
| 2017 | 1.16 Million AUD | 12.5% |
| 2016 | 1.03 Million AUD | -49.73% |
| 2015 | 2.05 Million AUD | 1245.89% |
| 2014 | 152.53 Thousand AUD | -58.49% |
| 2013 | 367.51 Thousand AUD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 FY | -640.83 Thousand AUD | -137.87% |
| 2024 Q4 | -532.83 Thousand AUD | 0.0% |
| 2024 Q2 | -108 Thousand AUD | 0.0% |
| 2023 FY | 1.69 Million AUD | 345.22% |
| 2023 Q4 | 1.18 Million AUD | 0.0% |
| 2023 Q2 | 507 Thousand AUD | 0.0% |
| 2022 Q4 | -274 Thousand AUD | 0.0% |
| 2022 FY | -690 Thousand AUD | 12.55% |
| 2022 Q2 | -416 Thousand AUD | 0.0% |
| 2021 Q2 | -386 Thousand AUD | 0.0% |
| 2021 Q4 | -403 Thousand AUD | 0.0% |
| 2021 FY | -789 Thousand AUD | -216.54% |
| 2020 Q2 | 678 Thousand AUD | 0.0% |
| 2020 Q4 | -1000.00 AUD | 0.0% |
| 2020 FY | 677 Thousand AUD | -58.87% |
| 2019 FY | 1.64 Million AUD | -65.48% |
| 2019 Q4 | 798 Thousand AUD | 0.0% |
| 2019 Q2 | 495 Thousand AUD | 0.0% |
| 2018 Q4 | 2.72 Million AUD | 0.0% |
| 2018 Q2 | 2.04 Million AUD | 0.0% |
| 2018 FY | 4.76 Million AUD | 310.68% |
| 2017 Q2 | 664 Thousand AUD | 0.0% |
| 2017 FY | 1.16 Million AUD | 12.5% |
| 2017 Q4 | 497 Thousand AUD | 0.0% |
| 2016 FY | 1.03 Million AUD | -49.73% |
| 2015 Q2 | - AUD | 0.0% |
| 2015 FY | 2.05 Million AUD | 1245.89% |
| 2015 Q3 | - AUD | 0.0% |
| 2014 FY | 152.53 Thousand AUD | -58.49% |
| 2013 FY | 367.51 Thousand AUD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| 4DMedical Limited | 3.51 Million AUD | 118.218% |
| Aroa Biosurgery Limited | 53.98 Million AUD | 101.187% |
| Atomo Diagnostics Limited | 1.43 Million AUD | 144.604% |
| Anteris Technologies Ltd | 2.51 Million AUD | 125.458% |
| Control Bionics Limited | 3.67 Million AUD | 117.448% |
| CardieX Limited | 10.1 Million AUD | 106.34% |
| Compumedics Limited | 26.06 Million AUD | 102.458% |
| Cochlear Limited | 1.69 Billion AUD | 100.038% |
| CleanSpace Holdings Limited | 11.35 Million AUD | 105.641% |
| Cyclopharm Limited | 4.49 Million AUD | 114.249% |
| EMVision Medical Devices Ltd | 11.21 Million AUD | 105.712% |
| Nova Eye Medical Limited | 20.19 Million AUD | 103.174% |
| HeraMED Limited | -504.09 Thousand AUD | -27.126% |
| Imricor Medical Systems, Inc. | -1.99 Million AUD | 67.844% |
| ImpediMed Limited | 9 Million AUD | 107.116% |
| InhaleRx Limited | 1.2 Million AUD | 153.223% |
| LBT Innovations Limited | -2.91 Million AUD | 78.031% |
| Micro-X Limited | 5.73 Million AUD | 111.17% |
| Neurotech International Limited | -5867.00 AUD | -10822.703% |
| OncoSil Medical Limited | 55.63 Thousand AUD | 1251.918% |
| PolyNovo Limited | 36.08 Million AUD | 101.776% |
| Respiri Limited | 456.91 Thousand AUD | 240.253% |
| SomnoMed Limited | 55.13 Million AUD | 101.162% |
| Universal Biosensors, Inc. | 4.28 Million AUD | 114.956% |
| Uscom Limited | 3.11 Million AUD | 120.568% |
| Visioneering Technologies, Inc. | -271.11 Thousand AUD | -136.369% |